Selected research
Industry Research
Sevoflurane Vaporizer Industry Research Report 2026
Market perspective
The global Sevoflurane Vaporizer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sevoflurane Vaporizer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sevoflurane Vaporizer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sevoflurane Vaporizer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sevoflurane Vaporizer include Dräger, GE Healthcare, Mindray, Spacelabs Healthcare, Maquet, Baxter, Oricare, STEPHAN and Medec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sevoflurane Vaporizer market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sevoflurane Vaporizer Market by Company
Dräger
GE Healthcare
Mindray
Spacelabs Healthcare
Maquet
Baxter
Oricare
STEPHAN
Medec
Foshan Gladent
Hersill
Dragerwerk
Penlon
Nipro
Sevoflurane Vaporizer Segment by Type
Active Temperature Compensation
Passive Temperature Compensation
Sevoflurane Vaporizer Segment by Application
Surgical Anesthesia
Medical Research
Animal Anesthesia
Others
Sevoflurane Vaporizer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane Vaporizer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane Vaporizer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane Vaporizer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sevoflurane Vaporizer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sevoflurane Vaporizer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sevoflurane Vaporizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Active Temperature Compensation
- Passive Temperature Compensation
Applications
- Surgical Anesthesia
- Medical Research
- Animal Anesthesia
- Others
Companies covered
- Dräger
- GE Healthcare
- Mindray
- Spacelabs Healthcare
- Maquet
- Baxter
- Oricare
- STEPHAN
- Medec
- Foshan Gladent
- Hersill
- Dragerwerk
- Penlon
- Nipro
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sevoflurane Vaporizer Market Size (2021-2032)
- 2.2.2 Global Sevoflurane Vaporizer Sales (2021-2032)
- 2.2.3 Global Sevoflurane Vaporizer Market Average Price (2021-2032)
- 2.3 Sevoflurane Vaporizer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Active Temperature Compensation
- 2.3.3 Passive Temperature Compensation
- 2.4 Sevoflurane Vaporizer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgical Anesthesia
- 2.4.3 Medical Research
- 2.4.4 Animal Anesthesia
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sevoflurane Vaporizer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sevoflurane Vaporizer Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Sevoflurane Vaporizer Revenue of Manufacturers (2021-2026)
- 3.4 Global Sevoflurane Vaporizer Average Price by Manufacturers (2021-2026)
- 3.5 Global Sevoflurane Vaporizer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sevoflurane Vaporizer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sevoflurane Vaporizer, Product Type & Application
- 3.8 Global Manufacturers of Sevoflurane Vaporizer, Established Date
- 3.9 Global Sevoflurane Vaporizer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Dräger
- 4.1.1 Dräger Company Information
- 4.1.2 Dräger Business Overview
- 4.1.3 Dräger Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Dräger Sevoflurane Vaporizer Product Portfolio
- 4.1.5 Dräger Recent Developments
- 4.2 GE Healthcare
- 4.2.1 GE Healthcare Company Information
- 4.2.2 GE Healthcare Business Overview
- 4.2.3 GE Healthcare Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GE Healthcare Sevoflurane Vaporizer Product Portfolio
- 4.2.5 GE Healthcare Recent Developments
- 4.3 Mindray
- 4.3.1 Mindray Company Information
- 4.3.2 Mindray Business Overview
- 4.3.3 Mindray Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mindray Sevoflurane Vaporizer Product Portfolio
- 4.3.5 Mindray Recent Developments
- 4.4 Spacelabs Healthcare
- 4.4.1 Spacelabs Healthcare Company Information
- 4.4.2 Spacelabs Healthcare Business Overview
- 4.4.3 Spacelabs Healthcare Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Spacelabs Healthcare Sevoflurane Vaporizer Product Portfolio
- 4.4.5 Spacelabs Healthcare Recent Developments
- 4.5 Maquet
- 4.5.1 Maquet Company Information
- 4.5.2 Maquet Business Overview
- 4.5.3 Maquet Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Maquet Sevoflurane Vaporizer Product Portfolio
- 4.5.5 Maquet Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Sevoflurane Vaporizer Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 Oricare
- 4.7.1 Oricare Company Information
- 4.7.2 Oricare Business Overview
- 4.7.3 Oricare Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Oricare Sevoflurane Vaporizer Product Portfolio
- 4.7.5 Oricare Recent Developments
- 4.8 STEPHAN
- 4.8.1 STEPHAN Company Information
- 4.8.2 STEPHAN Business Overview
- 4.8.3 STEPHAN Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 STEPHAN Sevoflurane Vaporizer Product Portfolio
- 4.8.5 STEPHAN Recent Developments
- 4.9 Medec
- 4.9.1 Medec Company Information
- 4.9.2 Medec Business Overview
- 4.9.3 Medec Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Medec Sevoflurane Vaporizer Product Portfolio
- 4.9.5 Medec Recent Developments
- 4.10 Foshan Gladent
- 4.10.1 Foshan Gladent Company Information
- 4.10.2 Foshan Gladent Business Overview
- 4.10.3 Foshan Gladent Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Foshan Gladent Sevoflurane Vaporizer Product Portfolio
- 4.10.5 Foshan Gladent Recent Developments
- 4.11 Hersill
- 4.11.1 Hersill Company Information
- 4.11.2 Hersill Business Overview
- 4.11.3 Hersill Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hersill Sevoflurane Vaporizer Product Portfolio
- 4.11.5 Hersill Recent Developments
- 4.12 Dragerwerk
- 4.12.1 Dragerwerk Company Information
- 4.12.2 Dragerwerk Business Overview
- 4.12.3 Dragerwerk Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dragerwerk Sevoflurane Vaporizer Product Portfolio
- 4.12.5 Dragerwerk Recent Developments
- 4.13 Penlon
- 4.13.1 Penlon Company Information
- 4.13.2 Penlon Business Overview
- 4.13.3 Penlon Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Penlon Sevoflurane Vaporizer Product Portfolio
- 4.13.5 Penlon Recent Developments
- 4.14 Nipro
- 4.14.1 Nipro Company Information
- 4.14.2 Nipro Business Overview
- 4.14.3 Nipro Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Nipro Sevoflurane Vaporizer Product Portfolio
- 4.14.5 Nipro Recent Developments
5 Global Sevoflurane Vaporizer Market Scenario by Region
- 5.1 Global Sevoflurane Vaporizer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sevoflurane Vaporizer Sales by Region: 2021-2032
- 5.2.1 Global Sevoflurane Vaporizer Sales by Region: 2021-2026
- 5.2.2 Global Sevoflurane Vaporizer Sales by Region: 2027-2032
- 5.3 Global Sevoflurane Vaporizer Revenue by Region: 2021-2032
- 5.3.1 Global Sevoflurane Vaporizer Revenue by Region: 2021-2026
- 5.3.2 Global Sevoflurane Vaporizer Revenue by Region: 2027-2032
- 5.4 North America Sevoflurane Vaporizer Market Facts & Figures by Country
- 5.4.1 North America Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sevoflurane Vaporizer Sales by Country (2021-2032)
- 5.4.3 North America Sevoflurane Vaporizer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sevoflurane Vaporizer Market Facts & Figures by Country
- 5.5.1 Europe Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sevoflurane Vaporizer Sales by Country (2021-2032)
- 5.5.3 Europe Sevoflurane Vaporizer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sevoflurane Vaporizer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sevoflurane Vaporizer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sevoflurane Vaporizer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sevoflurane Vaporizer Market Facts & Figures by Country
- 5.7.1 South America Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sevoflurane Vaporizer Sales by Country (2021-2032)
- 5.7.3 South America Sevoflurane Vaporizer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sevoflurane Vaporizer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sevoflurane Vaporizer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sevoflurane Vaporizer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sevoflurane Vaporizer Sales by Type (2021-2032)
- 6.1.1 Global Sevoflurane Vaporizer Sales by Type (2021-2032) & (units)
- 6.1.2 Global Sevoflurane Vaporizer Sales Market Share by Type (2021-2032)
- 6.2 Global Sevoflurane Vaporizer Revenue by Type (2021-2032)
- 6.2.1 Global Sevoflurane Vaporizer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sevoflurane Vaporizer Revenue Market Share by Type (2021-2032)
- 6.3 Global Sevoflurane Vaporizer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sevoflurane Vaporizer Sales by Application (2021-2032)
- 7.1.1 Global Sevoflurane Vaporizer Sales by Application (2021-2032) & (units)
- 7.1.2 Global Sevoflurane Vaporizer Sales Market Share by Application (2021-2032)
- 7.2 Global Sevoflurane Vaporizer Revenue by Application (2021-2032)
- 7.2.1 Global Sevoflurane Vaporizer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sevoflurane Vaporizer Revenue Market Share by Application (2021-2032)
- 7.3 Global Sevoflurane Vaporizer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sevoflurane Vaporizer Value Chain Analysis
- 8.1.1 Sevoflurane Vaporizer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sevoflurane Vaporizer Production Mode & Process
- 8.2 Sevoflurane Vaporizer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sevoflurane Vaporizer Distributors
- 8.2.3 Sevoflurane Vaporizer Customers
9 Global Sevoflurane Vaporizer Analyzing Market Dynamics
- 9.1 Sevoflurane Vaporizer Industry Trends
- 9.2 Sevoflurane Vaporizer Industry Drivers
- 9.3 Sevoflurane Vaporizer Industry Opportunities and Challenges
- 9.4 Sevoflurane Vaporizer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst